By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Revenue from sales of self-manufactured Traditional Chinese Medicine Derivatives (TCMD) products13.26M74.25%
Revenue from sales of third-party products4.6M25.75%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
People’s Republic of China (PRC)17.86M100.00%